This is a collection of links I've accumulated about the drug Ivermectin and its use against COVID-19. This drug is safe, cheap (patent-expired), widely available, FDA approved for many uses, classified by the WHO as "essential medicine", and extremely effective against SARS-CoV-2 and COVID-19, both as prophylaxis and in every stage of the disease. Ivermectin has even proven to be effective against cancer. One can only speculate as to why the media has not picked up on this but it is becoming increasingly clear that there is big money to be lost if the public finds out.
Ask your doctor to prescribe Ivermectin. If you can’t find a doctor who will prescribe it for you, the animal version is the same drug and has been taken safely by many during this pandemic.
This page will be updated as new information comes in.
In vitro Study
FLCCCThis is the group that should end it all. The Frontline COVID-19 Critical Care Alliance (FLCCC), is a group of prominent critical care physicians who have been treating COVID-19 patients since the pandemic began and have been earnestly searching the scientific literature for “signals of efficacy” among all the treatments being used throughout the world. They have reviewed the evidence to date and called on the NIH, FDA, CDC, WHO and other governing agencies to immediately approve ivermectin for the prevention and treatment of every stage of COVID-19. Below is a sample of some of their work and the video of their press conference.
FLCCC Alliance Invited to the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel to Present Latest Data on Ivermectin
Some doctors think they’ve found a cheap, generic drug which treats COVID-19. So why hasn’t anyone heard of it?
Hospitalized and Outpatient
Papers on other diseases (for more on Ivermectin vs. Cancer see here.)
SILAC quantitative proteomics analysis of ivermectin‐related
proteomic profiling and molecular network alterations in human
ovarian cancer cells
Serious Neurological Adverse Events after Ivermectin—Do They
Occur beyond the Indication of Onchocerciasis?
SILAC quantitative proteomics analysis of ivermectin‐related proteomic profiling and molecular network alterations in human ovarian cancer cells
Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?